Share
Market Research Report

U.S. TRANSTHYRETIN AMYLOIDOSIS TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By TypeHereditary Transthyretin Amyloidosis (hATTR-CM) and Wild Type Amyloidosis
  • By Drug TypeTafamidis · Diflunisal · Inotersen · Patisiran · Tolcapone · and Others
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · and Online Pharmacies
  • Published In03 Apr 2026
  • Report CodeCMI1919
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • U.S. Transthyretin Amyloidosis Treatment Market, By Type
      • U.S. Transthyretin Amyloidosis Treatment Market, By Drug Type
      • U.S. Transthyretin Amyloidosis Treatment Market, By Distribution Channel
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
    • Epidemiology
  4. U.S. Transthyretin Amyloidosis Treatment Market, By Type, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hereditary Transthyretin Amyloidosis (hATTR-CM)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Wild Type Amyloidosis (wATTR-CM)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  5. U.S. Transthyretin Amyloidosis Treatment Market, By Drug Type, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Tafamidis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Diflunisal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Inotersen
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Patisiran
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Tolcapone
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  6. U.S. Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  7. Competitive Landscape

    • Alnylam Pharmaceuticals, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Pfizer, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Prothena Corporation Plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • GSK plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Ionis Pharmaceuticals, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • SOM Innovation Biotech, S.L.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Eidos Therapeutics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • BridgeBio Pharma, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bristol-Myers Squibb Company
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AstraZeneca
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Acrotech Biopharma
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Attralus, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  8. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  9. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 28 market data tables and 24 figures on 'Transthyretin Amyloidosis Treatment Market' – U.S. forecast to 2033